Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,876 | -53,134 | -64,891 | -81,678 | -48,722 |
| Depreciation Amortization | 265,288 | 192,341 | 125,352 | 62,331 | 240,948 |
| Accounts receivable | -162,155 | -134,514 | -156,471 | -55,735 | 125,799 |
| Other Working Capital | -4,068 | -25,923 | -68,691 | -11,974 | -47,186 |
| Other Operating Activity | 269,910 | 198,251 | 199,948 | 82,646 | 74,738 |
| Operating Cash Flow | $295,099 | $177,021 | $35,247 | $-4,410 | $345,577 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -60,340 | -37,876 | -20,764 | -10,060 | -46,801 |
| Purchase Sale Intangibles | -14,650 | -14,050 | -10,450 | -9,700 | -22,388 |
| Other Investing Activity | -2,656 | -9,061 | -5,461 | -9,700 | -22,388 |
| Investing Cash Flow | $-62,996 | $-46,937 | $-26,225 | $-19,760 | $-69,189 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 48,000 | 48,000 | N/A | N/A |
| Debt Issued | 48,000 | N/A | N/A | 48,000 | 436,732 |
| Debt Repayment | -188,918 | -133,383 | -90,373 | -63,377 | -414,080 |
| Common Stock Issued | 1,154 | 1,003 | 386 | 28 | 451 |
| Other Financing Activity | -72,027 | -66,207 | -16,254 | -7,806 | -235,676 |
| Financing Cash Flow | $-211,791 | $-150,587 | $-58,241 | $-23,155 | $-212,573 |
| Exchange Rate Effect | -999 | -259 | -266 | -165 | 65 |
| Beginning Cash Position | 99,107 | 99,107 | 99,107 | 99,107 | 35,227 |
| End Cash Position | 118,420 | 78,345 | 49,622 | 51,617 | 99,107 |
| Net Cash Flow | $19,313 | $-20,762 | $-49,485 | $-47,490 | $63,880 |
| Free Cash Flow | |||||
| Operating Cash Flow | 295,099 | 177,021 | 35,247 | -4,410 | 345,577 |
| Capital Expenditure | -60,340 | -37,876 | -20,764 | -10,060 | -46,801 |
| Free Cash Flow | 234,759 | 139,145 | 14,483 | -14,470 | 298,776 |